# OnCo record nct06850090 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06850090/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06850090", "NCT06850090" ;
  schema:name "Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial"@en ;
  schema:description "A phase 3 trial of trifluridine/tipiracil and capecitabine in colorectal cancer, run by Shandong Cancer Hospital and Institute, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06850090/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06850090> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/capecitabine/> .